DNMT3A (NM_022552) Human Mass Spec Standard

CAT#: PH313064

DNMT3A MS Standard C13 and N15-labeled recombinant protein (NP_072046)



  View other "DNMT3A" proteins (3)

Need it in bulk or customized?
Get a free quote

CNY 19,520.00


货期*
4周

规格
    • 10 ug

Cited in 1 publication.

Product images

经常一起买 (2)
Transient overexpression lysate of DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), transcript variant 3
    • 100 ug

CNY 4,840.00


Mouse Monoclonal DNMT3A Antibody (64B1446)
    • 100 ug

CNY 6,188.00

Specifications

Product Data
Description DNMT3A MS Standard C13 and N15-labeled recombinant protein (NP_072046)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC213064
Predicted MW 101.9 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_072046
RefSeq Size 4324
RefSeq ORF 2736
Synonyms DNMT3A2; HESJAS; M.HsaIIIA; TBRS
Locus ID 1788
Cytogenetics 2p23.3
Summary CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated. [provided by RefSeq, Mar 2016]
Protein Families Druggable Genome
Protein Pathways Cysteine and methionine metabolism, Metabolic pathways
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (1)

Documents

Other Versions

Customer Reviews 
Loading...